Navigation Links
Need for early screening and effective cancer treatment in India

Cancer shares a lot of symptoms with general diseases like tuberculosis and persistent cough, a warning for people to seek early screening and treatment.

Mouth ulcers, a fever not abating, an incurable cough, a growing mole // or a wound that does not heal fast are symptoms that need to be screened for cancer.

Unlike in the US, where the cure rate is 55 percent as two-thirds of the people seek treatment in the first and second stages, in India it is the reverse as most seek treatment only in the second or third stage. This reduces the chances of a cure.

Though colon and rectum cancer is so far not among the top five cancers in India, this may not remain the case as Indians increasingly switch to a western lifestyle and non-vegetarian diets. Most patients with colorectal cancer seek treatment only when they are into advanced stages, making treatment a big challenge.

The rate of cure varies from 10 to 50 % depending on the stage and time of presentation, which clearly emphasizes the need for early screening for cancer. Furthermore, patients in the first and second stages have more treatment options and lesser chances of a relapse.

By 2025-30, according to the World Health Organization, India is expected to peak with all kinds of cancer. Cancer is expected to become a chronic disease and the effectiveness of therapy could depend on chronic treatments as in the case of diabetes or other similar health problems.

Source: IANS
'"/>




Page: 1

Related medicine news :

1. Gene linked to early puberty in girls
2. Cancer drugs in development nearly doubled since 1995
3. Nearly all asthma deaths preventable
4. Ductal lavage may detect early breast cancer
5. Doctors advice early anemia tests
6. Heart disease threat starts early in life for Diabetics
7. Heart disease starts early
8. Cardiac diseases develop early
9. Rubella nearly wiped out
10. Schizophrenia detected early
11. Ultrasound test may detect heart condition early
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: